More severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain-Barré syndrome in northeast China

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Wu, Xiujuan ^a   Wu, Wei ^a   Wang, Zhengzheng ^a   Shen, Donghui ^a   Pan, Wei ^a   Wang, Ying ^a,b   Wu, Limin ^a,c   Wu, Xiaokun ^a   Feng, Jiachun ^a   Liu, Kangding ^a   Zhu, Jie ^a,d   Zhang, Hong Liang ^a,d  

^a JILIN UNIVERSITY   (China)

^b Basic Medical College   (China)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GANGLIOSIDE; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GT1A ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ACUTE MOTOR AXONAL NEUROPATHY; ADULT; AGE; AGED; ANTIBODY DETECTION; ARTICLE; ARTIFICIAL VENTILATION; CEREBROSPINAL FLUID; CHINA; CONTROLLED STUDY; CRANIAL NERVE; DEMYELINATING NEUROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GUILLAIN BARRE SYNDROME; HUGHES FUNCTIONAL GRADING SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL SUM SCORE; MIDDLE AGED; PROGNOSIS; PROTEIN BLOOD LEVEL; RATING SCALE; SCORING SYSTEM; ADOLESCENT; BLOOD; CHEMICALLY INDUCED; DEMOGRAPHY; ELECTROPHYSIOLOGY; IMMUNOLOGY; NERVE FIBER; PATHOLOGY; TIME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; AXONS; CHINA; DEMOGRAPHY; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TIME FACTORS; YOUNG ADULT;

EID: 84905379086     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104074     Document Type: Article

References (25)

1. Zhang HL, Zheng XY, Zhu J (2013) Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev 24:443-453.
2. Kuwabara S, Yuki N (2013) Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol 12:1180-1188.
3. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, et al. (1993) Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33:333-342. (Pubitemid 23103964)
4. Hafer-Macko C, Hsieh ST, Li CY, Ho TW, Sheikh K, et al. (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40:635-644. (Pubitemid 26357889)
5. Nobile-Orazio E, Carpo M, Meucci N, Grassi MP, Capitani E, et al. (1992) Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci 109:200-206.
6. Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, et al. (1995) Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol 38:218-224.
7. Odaka M, Yuki N, Nobile-Orazio E, Carpo M, Hirata K (2000) Antibodies to GM1 (NeuGc) in Guillain-Barré syndrome after ganglioside therapy. J Neurol Sci 175:96-106. (Pubitemid 30265475)
8. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, et al. (2001) Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49:712-720. (Pubitemid 32530237)
9. Figueras A, Morales-Olivas FJ, Capella D, Palop V, Laporte JR (1992) Bovine gangliosides and acute motor polyneuropathy. BMJ 305:1330-1331.
10. Asbury AK, Cornblath DR (1990). Assessment of current diagnostic criteria for Guillain-Barré syndrome. Annals of Neurology 27:S21-S24. (Pubitemid 20178648)
11. Zhou CK, Wu LM, Ni FM, Ji W, Wu J, et al. (2014) Critical illness polyneuropathy and myopathy: a systematic review. Neural Regen Res 9:101-110.
12. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, et al. (1998) Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 44:780-788. (Pubitemid 28516049)
13. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2:750-753. (Pubitemid 9034500)
14. Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14:1103-1109.
15. Garattini S, Garattini L (1993) Pharmaceutical prescriptions in four European countries. Lancet 342:1191-1192. (Pubitemid 23331706)
16. Landi G, D'Alessandro R, Currò Dossi B, Ricci S, Simone IL, et al. (1993) Guillain-Barré syndrome after exogenous gangliosides in Italy. BMJ 307:1463-1464. (Pubitemid 23351436)
17. Granieri E, Casetta I, Govoni V, Tola MR, Paolino E, et al. (1991) Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association. Neuroepidemiology 10:161-169.
18. Díez-Tehedor E, Gutiérrez-Rivas E, Gil-Peralta A (1993) Gangliosides and Guillain-Barré syndrome: the Spanish data. Neuroepidemiology 12:251-256. (Pubitemid 24019429)
19. Govoni V, Granieri E, Casetta I, Tola MR, Paolino E, et al. (1996) The incidence of Guillain-Barré syndrome in Ferrara, Italy: is the disease really increasing? J Neurol Sci 137:62-68.
20. Govoni V, Granieri E, Tola MR, Paolino E, Casetta I, et al. (1997) Exogenous gangliosides and Guillain-Barré syndrome: An observational study in the local health district of Ferrara, Italy. Brain 120:1123-1130. (Pubitemid 27285731)
21. Govoni V, Granieri E, Manconi M, Capone J, Casetta I (2003) Is there a decrease in Guillain-Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy. J Neurol Sci 216:99-103. (Pubitemid 37371872)
22. Yuki N, Odaka M (2005) Ganglioside mimicry as a cause of Guillain-Barré syndrome. Curr Opin Neurol 18:557-561. (Pubitemid 41476143)
23. Islam Z, Gilbert M, Mohammad QD, Klaij K, Li J, et al. (2012) Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS One 7:e43976.
24. Gao B, Tsan MF (2003) Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor α release by murine macrophages. J Biol Chem 278:174-179. (Pubitemid 36043559)
25. Gao B, Tsan MF (2003) Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor α from murine macrophages. J Biol Chem 278:22523-22529. (Pubitemid 36830307)